SEELEY BRUCE J. 4
4 · CTI BIOPHARMA CORP · Filed Mar 11, 2022
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2021-06-30$2.13/sh+3,164$6,724→ 40,664 total - Award
Common Stock
2021-12-31$2.11/sh+3,241$6,832→ 43,905 total - Award
Stock Option (right to buy)
2022-03-09+280,000→ 280,000 totalExercise: $4.49Exp: 2032-03-09→ Common Stock (280,000 underlying)
Footnotes (2)
- [F1]Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.
- [F2]The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates.